Researchers from Lund University in Sweden have discovered higher levels of immune proteins in the blood before and after an epileptic seizure. The possible biomarkers can be identified using a simple ...

Takeda’s late-phase epilepsy program has failed a key test, chalking up misses on the primary endpoints in pivotal trials in two indications. But the Japanese drugmaker still plans to talk to ...

The University of Utah College of Pharmacy's Anticonvulsant Drug Development (ADD) Program has been awarded a five-year $19.5 million contract renewal with the National Institutes of Health (NIH) to ...

Noninvasive tests performed in midlife may help identify people who are at risk of late-onset epilepsy (LOE), a new study suggests. New data from the Framingham Heart Study show those who scored ...

A new clinical trial co-led by researchers at FutureNeuro and RCSI University of Medicine and Health Sciences is investigating how advanced brain monitoring could improve the diagnosis and management ...

AIIMS Delhi has resumed free Therapeutic Drug Monitoring (TDM) tests for epilepsy patients. This initiative reduces financial ...

Oregon paramedics will start testing a drug that could some day let people treat long, dangerous seizures even before an ambulance arrives. If the test works, it could give a new anti-seizure tool not ...

Epilepsy presents differently in each person. The condition has a range of symptoms that varies. Convulsions can be one sign of epilepsy. However, people often experience epilepsy without ever having ...

Patients with functional seizures had slightly better cognitive performance than those with epilepsy, but worse performance compared with a healthy cohort of patients, according to a systematic review ...